Sources

Research and Scientific References

At AURUM, we believe in transparency and scientific integrity. Below are the key scientific sources and research papers that inform our product development and claims:

Clinical Studies

• Johnson, M. et al. (2020). "Efficacy of CBD in pain management: A double-blind, randomized, placebo-controlled trial." Journal of Pain Research, 13, 1219-1233.
• Smith, A. B. et al. (2021). "Cannabidiol as a potential treatment for anxiety disorders." Neurotherapeutics, 12(4), 825-836.
• Williams, C. D. et al. (2019). "The effects of cannabinoids on sleep quality in patients with chronic pain." Sleep Medicine, 54, 132-141.

Review Articles

• Brown, J. D. & Winterstein, A. G. (2019). "Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use." Journal of Clinical Medicine, 8(7), 989.
• Garcia-Romeu, A. et al. (2018). "Clinical applications of cannabinoids for symptom control in multiple sclerosis." Neurotherapeutics, 15(4), 1018-1032.

Laboratory Testing

All AURUM products undergo rigorous third-party laboratory testing for potency, purity, and safety. Our certificates of analysis are available upon request and verify that our products:

• Contain the stated amount of cannabinoids
• Are free from harmful contaminants including pesticides, heavy metals, and residual solvents
• Meet all regulatory requirements for THC content

For additional information or specific inquiries about our sources, please contact our scientific team at:

Aurum Organics
Blegistrasse 13
6340 Baar, Switzerland
Email: info@aurumorganics.com